Korean College of Helicobacter and Upper Gastrointestinal Research

Today 2020.12.04 D-DAY 105

Scientific Program

Program Details

  >  Scientific Program  >  Program Details

Program is subject to change.

8:00 Registration
9:00-9:40 Free paper session 1
Chairs: Dong Ho Lee (Seoul National University, Korea), Jung Mogg Kim (Hanyang University, Korea)
09:00-09:10 Efficacies of a tailored eradication strategy versus empirical bismuth-containing quadruple therapy as first-line eradication for Helicobacter pylori infection in Korean patients: A prospective, comparative, open trial Youn I Choi
(Gachon University, Korea)
09:10-09:20 Current trend in the Helicobacter pylori eradication rates of first-line sequential and concomitant therapies in Korea: A nationwide multicenter retrospective study over the 9 years Byung-Wook Kim
(The Catholic University of Korea, Korea)
09:20-09:30 Follow up reinfection situation of Helicobacter pylori after successful eradication: A single-center study in Vietnam Nguyen Thi Hao
(Hanoi Medical University, Vietnam)
09:30-09:40 Changes in the fluoroquinolone resistance of Helicobacter pylori over a 14-year period and discovery of a novel mutation in DNA gyrase: A single-center study in Korea Jae Yong Park
(Chung-Ang University, Korea)
9:40-10:20 Free paper session 2
Chairs: Hoon Jai Chun (Korea University, Korea), Jeong Seop Moon (Inje University, Korea)
09:40-09:50 Clinical significance of TWIST-expressing circulating tumor cells in patients with esophageal squamous cell carcinoma Moon Won Lee
(Pusan National University, Korea)
09:50-10:00 Tumour infiltrating lymphocytes assessed on haematoxylin eosin stained pre-treatment biopsies of oesophageal cancer patients predict benefit from chemotherapy - Results from the UK MRC OE02 trial Maximilian Häller
(Maastricht University Medical Center+, Netherlands)
10:00-10:10 The effect of Helicobacter pylori infection and eradication on the tight junction in the gastric mucosal barrier Sooin Choi
(Seoul National University, Korea)
10:10-10:20 Alcian blue - a rediscovered biomarker of poor prognosis in gastric cancer patients Drolaiz Liu
(Maastricht University Medical Center+, Netherlands)
10:20-11:00 Free paper session 3
Chairs: Ok-Jae Lee (Gyeongsang National University, Korea), Hwoon-Yong Jung (University of Ulsan, Korea)
10:20-10:30 Risk factors for lymph node metastasis and mortality after non-curative resection of undifferentiated early gastric cancer Hyo-Joon Yang
(Sungkyunkwan University, Korea)
10:30-10:40 Development of prediction model for gastric cancer using artificial intelligence based on the big data cohort and single nucleotide poylmorphism in Korea cohort Chung Hyun Tae
(Ewha Womans University, Korea)
10:40-10:50 Infectious events after endoscopic procedures in hematologic patients with neutropenia Ga-Yeong Shin
(The Catholic University of Korea, Korea)
10:50-11:00 Clinical outcomes of enteral feeding protocol via percutaneous endoscopic gastrostomy: A single center, retrospective study Jin Hee Noh
(University of Ulsan, Korea)
11:00-11:30 Break
11:30-12:50 Scientific session 4: Are we doing our best in the era of the resistant H. pylori prevailing?
Chairs: Yong Chan Lee (Yousei University, Korea), Jae Myung Park(The Catholic University of Korea, Korea)
11:30-11:50 Reconciliation of H. pylori guidelines in Western countries: First and second line regimens Steven F. Moss
(Brown University, USA)
11:50-12:10 Reconciliation of H. pylori guidelines in Eastern countries: First and second line regimens Mototsugu Kato
(National Hospital Organization Hakodate National Hospital, Japan)
12:10-12:30 Profiling the resistance: Genotyping based Byung-Wook Kim
(The Catholic University of Korea, Korea)
12:30-12:50 Discussion
12:50-13:50 Luncheon Symposium 2
Chairs: Jae Gyu Kim (Chung-Ang University, Korea), Sun Moon Kim (Konyang University, Korea)
12:50-13:50 Patients centered approach to management of upper GI diseases focused on PPI Jun Haeng Lee
(Sungkyunkwan University, Korea)
13:50-15:10 Scientific session 5: Chemopreventive strategies in upper GI cancer
Chairs: Jong-Jae Park (Korea University, Korea), Su Jin Hong (Soon Chun Hyang University, Korea)
13:50-14:10 Effect on H. pylori eradication therapy against gastric cancer Hidekazu Suzuki
(Tokai University, Japan)
14:10-14:30 Metformin use and gastric cancer risk Wai K. Leung
(University of Hong Kong, Hong Kong)
14:30-14:50 Chemopreventive effect of aspirin against gastric cancer Il Ju Choi
(National Cancer Center, Korea)
14:50-15:10 Discussion
15:10-15:30 Break
15:30-16:50 Scientific session 6: KCHUGR-VFDE Joint Symposium
Chairs: Jae Gyu Kim (Chung-Ang University, Korea), Sung Kwan Shin (Yonsei University, Korea)
15:30-15:45 Diagnosis of H. pylori infection in Vietnamese Children: What are the differences between adults and children? Vu Van Khien
(108 Central Hospital, Vietnam)
15:45-16:00 A potential biomarker panel to distinguish gastric cancer from duodenal ulcer: Result from GWAS in East Asian-type H. pylori Vo Phuoc Tuan
(Cho Ray Hospital, Vietnam)
16:00-16:15 Guidelines for the treatment of Helicobacter pylori infection in Korea, 2020 revised edition
- Newly added indication for H. pylori infection
Cheol Min Shin
(Seoul National University, Korea)
16:15-16:30 Guidelines for the treatment of Helicobacter pylori infection in Korea, 2020 revised edition
- Recent evidence for H. pylori eradication
Hyo-Joon Yang
(Sungkyunkwan University, Korea)
16:30-16:50 Discussion
16:50 Closing Remark